Multi Institutional Study in Patient Presenting With Hematuria

Status unconfirmed

Conditions studied: Bladder Cancer, Hematuria

In brief

The primary objective of this study is to evaluate the performance of the methylation marker panel for the detection of bladder cancer in patients with gross or microscopic hematuria.

Key facts

Study ID

NCT03122964

Run by

MDx Health

People needed

1148

Starts

2017-03-31

Expected to finish

2020-02-28

Last updated by the study team

2019-03-06

Who can join

Age: 40 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject is willing and able to give written informed consent
• Subject presents with or has a history of gross hematuria or microhematuria within the last 3 months

You may not qualify if…

• Subject has an active urinary tract infection, current urinary retention, active stone disease (renal or bladder), current ureteral stents or nephrostomy tubes, prior bowel interposition, or recent genitourinary instrumentation (within 10 days)
• Subject has a current or past history of genitourinary or urologic cancer within 5 years
• Subject has an active (untreated) cancer of any type, except basal cell skin cancer within 5 years

Where it is running

• UT Southwestern — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.